ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PASW vs NCI // NET PROFIT MARGIN

Ping An Biomedical Co. Ltd. (Class A) (NASDAQ) VS. Neo-Concept International Group Holdings Limited (Class A) (NASDAQ) • 15-METRIC TALLY: PASW 2 — NCI 4
▲ NET PROFIT MARGIN LEADER: NCI
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PASW VS. NCI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PASW NCI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 2.80% 36.90% -34.10 NCI /gross-margins <GO>
Return on Invested Capital (ROIC) — 2.60% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 9.3x — TIE /valuation <GO>
Free Cash Flow Yield -5.77% — — TIE /fcf-yield <GO>
Operating Margin -43.10% 1.30% -44.40 NCI /operating-margins <GO>
Net Profit Margin ACTIVE -37.60% 0.20% -37.80 NCI /net-margins <GO>
Revenue Growth (YoY) — -41.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.49 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 6/9 -5.00 NCI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.7 17.7 +33.99 PASW /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 140.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $15.6M $6.6M $9.1M PASW /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PASW REV NCI REV PASW GROSS % NCI GROSS % PASW FCF NCI FCF
FY 2025 $4.8M $17.6M 2.8% 36.9% -$902.9K $2.2M
FY 2024 — $30.3M — 21.0% — -$478.4K
FY 2023 — $22.3M — — — -$6.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PASW // BETA —
NCI // BETA —